Michael D. Alvarado MD
Breast, Surgical Oncology (Other than Breast)
Professor of Surgery, UCSF
Join to View Full Profile
1600 Divisadero StSan Francisco, CA 94143
Phone+1 415-353-7070
Fax+1 415-353-7050
Dr. Alvarado is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of South Florida Morsani/Moffitt Cancer CenterFellowship, Complex General Surgical Oncology, 2004 - 2006
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Surgery, 1998 - 2004
Geisel School of Medicine at DartmouthClass of 1998
Certifications & Licensure
CA State Medical License 2006 - 2028
FL State Medical License 2020 - 2022
NH State Medical License 2001 - 2009
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
- Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery Start of enrollment: 2012 May 18
Publications & Presentations
PubMed
- Longitudinal tumor-informed ctDNA monitoring for recurrence and treatment response in melanoma.Olivia Sleeper, Justin Fortino, Nam Woo Cho, Adil I Daud, Katy K Tsai
BMC Cancer. 2026-04-02 - 2 citationsOncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an in...Giacomo Montagna, Michael Alvarado, Sara Myers, Mary M Mrdutt, Susie X Sun
The Lancet. Oncology. 2026-01-01 - Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserv...Frank Vicini, Chirag Shah, Karuna Mittal, Sheila Weinmann, Michael Leo
International Journal of Radiation Oncology, Biology, Physics. 2025-11-15
Journal Articles
- Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 PatientsMerisa Piper, Jasmine Wong, Hani Sbitany, Cheryl Ewing, Michael Alvarado, Laura Esserman, Robert Foster, Annals of Surgical Oncology
- A Natural Killer–Dendritic Cell Axis Defines Checkpoint Therapy–Responsive Tumor MicroenvironmentsPatrick K Ha, William R Ryan, Nina Bhardwaj, Vincent Chan, Michael D Alvarado, Adil I Daud, Joy Hsu, Nature
Press Mentions
Endomag’s Sentimag and Sienna Demonstrated Non-Inferior to Standard of Care for Sentinel Node DetectionDecember 8th, 2016
Millions Fall Prey to This Deadly Breast Cancer MythAugust 26th, 2016
Immune-Cell Population Predicts Immunotherapy Response in MelanomaAugust 15th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
